Next, using immunohistochemistry and western blot assay, we found that EZH2 showed different expression levels in five cervical cancer cell lines, including HeLa, SiHa, C33A, CaSki and HT-3 (Supplementary Figure 1). This evidence concerns the gene EZH2 and cervical carcinoma.